![PARP inhibitors and epithelial ovarian cancer: Molecular mechanisms, clinical development and future prospective (Review) PARP inhibitors and epithelial ovarian cancer: Molecular mechanisms, clinical development and future prospective (Review)](https://www.spandidos-publications.com/article_images/ol/20/4/ol-20-04-11951-g00.jpg)
PARP inhibitors and epithelial ovarian cancer: Molecular mechanisms, clinical development and future prospective (Review)
![Cancers | Free Full-Text | Understanding Resistance Mechanisms and Expanding the Therapeutic Utility of PARP Inhibitors Cancers | Free Full-Text | Understanding Resistance Mechanisms and Expanding the Therapeutic Utility of PARP Inhibitors](https://pub.mdpi-res.com/cancers/cancers-09-00109/article_deploy/html/images/cancers-09-00109-g001.png?1569507871)
Cancers | Free Full-Text | Understanding Resistance Mechanisms and Expanding the Therapeutic Utility of PARP Inhibitors
![PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications | Molecular Cancer | Full Text PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications | Molecular Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12943-020-01167-9/MediaObjects/12943_2020_1167_Fig2_HTML.png)
PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications | Molecular Cancer | Full Text
![Current Clinical Application and Response Prediction Biomarkers of PARP Inhibitors | Bentham Science Current Clinical Application and Response Prediction Biomarkers of PARP Inhibitors | Bentham Science](https://www.eurekaselect.com/images/graphical-abstract/cppm/16/2/003.jpg)
Current Clinical Application and Response Prediction Biomarkers of PARP Inhibitors | Bentham Science
![PARP inhibitors mechanisms of action and resistance. The left part of... | Download Scientific Diagram PARP inhibitors mechanisms of action and resistance. The left part of... | Download Scientific Diagram](https://www.researchgate.net/publication/354011807/figure/fig3/AS:1058686164295680@1629421859910/PARP-inhibitors-mechanisms-of-action-and-resistance-The-left-part-of-the-figure.png)
PARP inhibitors mechanisms of action and resistance. The left part of... | Download Scientific Diagram
![Mechanism and current progress of Poly ADP-ribose polymerase (PARP) inhibitors in the treatment of ovarian cancer - ScienceDirect Mechanism and current progress of Poly ADP-ribose polymerase (PARP) inhibitors in the treatment of ovarian cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332219352837-gr1.jpg)
Mechanism and current progress of Poly ADP-ribose polymerase (PARP) inhibitors in the treatment of ovarian cancer - ScienceDirect
![Poly (ADP-ribose) polymerase (PARP) inhibitors as chemosensitizing compounds for the treatment of drug resistant cancers Poly (ADP-ribose) polymerase (PARP) inhibitors as chemosensitizing compounds for the treatment of drug resistant cancers](https://article.imrpress.com/journal/JMCM/2/3/10.31083/j.jmcm.2019.03.0303/2617-5282-2-3-55/img_2.jpg)
Poly (ADP-ribose) polymerase (PARP) inhibitors as chemosensitizing compounds for the treatment of drug resistant cancers
![Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action | Science Translational Medicine Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.aaf9246/asset/958ef6eb-1938-4191-a06f-4a5174e78f2d/assets/graphic/8-362ps17-f1.jpeg)
Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action | Science Translational Medicine
![JCM | Free Full-Text | PARP Inhibitors as a Therapeutic Agent for Homologous Recombination Deficiency in Breast Cancers JCM | Free Full-Text | PARP Inhibitors as a Therapeutic Agent for Homologous Recombination Deficiency in Breast Cancers](https://www.mdpi.com/jcm/jcm-08-00435/article_deploy/html/images/jcm-08-00435-g001.png)
JCM | Free Full-Text | PARP Inhibitors as a Therapeutic Agent for Homologous Recombination Deficiency in Breast Cancers
![Biomedicines | Free Full-Text | Role of PARP in TNBC: Mechanism of Inhibition, Clinical Applications, and Resistance Biomedicines | Free Full-Text | Role of PARP in TNBC: Mechanism of Inhibition, Clinical Applications, and Resistance](https://www.mdpi.com/biomedicines/biomedicines-09-01512/article_deploy/html/images/biomedicines-09-01512-g001.png)